Literature DB >> 31346894

ADPKD and metformin: from bench to bedside.

Ivana Capuano1, Eleonora Riccio2, Simona Caccavallo2, Imma De Simone2, Antonio Pisani2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31346894     DOI： 10.1007/s10157-019-01770-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  5 in total

1.  Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.

Authors:  Vinita Takiar; Saori Nishio; Patricia Seo-Mayer; J Darwin King; Hui Li; Li Zhang; Anil Karihaloo; Kenneth R Hallows; Stefan Somlo; Michael J Caplan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

2.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

3.  A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease.

Authors:  Stephen L Seliger; Kaleab Z Abebe; Kenneth R Hallows; Dana C Miskulin; Ronald D Perrone; Terry Watnick; Kyongtae Tae Bae
Journal:  Am J Nephrol       Date:  2018-05-18       Impact factor: 3.754

4.  Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.

Authors:  Ming-Yang Chang; Tsu-Lin Ma; Cheng-Chieh Hung; Ya-Chung Tian; Yung-Chang Chen; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

5.  Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?

Authors:  Antonio Pisani; Eleonora Riccio; Dario Bruzzese; Massimo Sabbatini
Journal:  BMC Nephrol       Date:  2018-10-22       Impact factor: 2.388
  5 in total
  2 in total

Review 1.  Therapeutic advances in ADPKD: the future awaits.

Authors:  Ivana Capuano; Pasquale Buonanno; Eleonora Riccio; Maria Amicone; Antonio Pisani
Journal:  J Nephrol       Date:  2021-05-19       Impact factor: 3.902

Review 2.  Metformin: the updated protective property in kidney disease.

Authors:  Qingjun Pan; Xing Lu; Chunfei Zhao; Shuzhen Liao; Xiaoqun Chen; Fengbiao Guo; Chen Yang; Hua-Feng Liu
Journal:  Aging (Albany NY)       Date:  2020-05-01       Impact factor: 5.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.